Anti-Human CD18 (ITGB2) In Vivo Antibody - Low Endotoxin
- SKU:
- IVMB0250
- Product Type:
- Hybridoma Monoclonal Antibody
- Clone:
- IB4
- Protein:
- CD18
- Isotype:
- IgG2a k
- Reactivity:
- Human
- Synonyms:
- Integrin beta-2
- integrin beta chain
- beta 2
- ITGB2
- Research Area:
- Cell Adhesion
- Cell Biology
- Immunology
- Signal Transduction
- Endotoxin Level:
- Low Endotoxin
- Host Species:
- Mouse
- Applications:
- FA
- FC
- IF Microscopy
- In Vivo
Description
Product Name: | Anti-Human CD18 (ITGB2) In Vivo Antibody - Low Endotoxin |
Product Code: | IVMB0250 |
Size: | 1 mg, 5 mg, 25 mg, 50 mg, 100 mg |
Clone: | IB4 |
Protein: | CD18 |
Product Type: | Hybridoma Monoclonal Antibody |
Synonyms: | Integrin beta-2, integrin beta chain, beta 2, ITGB2 |
Isotype: | IgG2a k |
Reactivity: | Human |
Applications: | FA, FC, IF Microscopy, In Vivo |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Product Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Applications: | FA, FC, IF Microscopy, In Vivo |
Reactivity: | Human |
Host Species: | Mouse |
Specificity: | IB4 activity is directed against human CD18 and can also stain rabbit bone marrow leukocytes. |
Antigen Distribution: | Depending on its heterodimeric configuration, CD18 is expressed in leukocytes, monocytes, macrophages, some lymphocytes, polymorphonuclear lymphocytes (PMNs), natural killer cells, neutrophils, granulocytes, certain lymphocytic tumor cell lines, macrophage foam cells, activated platelets, and splenic red pulp macrophages. |
Immunogen: | Human peripheral blood lymphocytes |
Concentration: | ≥ 5.0 mg/ml |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -70°C. Avoid Repeated Freeze Thaw Cycles. |